Institutional Biosafety Committee (IBC)

Home » Research Compliance Services » Institutional Biosafety Committee (IBC)
Institutional Biosafety Committee (IBC) 2017-04-27T15:08:54+00:00

The Maine Medical Center Institutional Biosafety Committee (IBC) is a standing committee that has oversight of recombinant DNA (rDNA) research.  All NIH funded rDNA research must be reviewed by the IBC per NIH Guidelines for Research Involving Recombinant DNA Molecules.

All activities proposed to involve the use of recombinant DNA must first seek approval from the Institutional Biosafety Committee. The IBC reviews and approves research to ensure safe practices, procedures, as well as handling and use of biohazardous materials for research at Maine Medical Center Research Institute.

Contact:

Calvin Vary, PhD
IBC Chairmain
varyc@mmc.org